Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 890 results found since Jan 2013.
Among Young Adults, More Women Than Men Have Ischemic Strokes
THURSDAY, Jan. 27, 2022 -- For young adults (aged 35 years or younger), the incidence of ischemic stroke is higher among women than men, according to a review published in the February issue of Stroke.
Michelle H. Leppert, M.D., from the University...
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news
Mankind Pharma announces foray into critical care
Saviour Mankind, a dedicated division for life-saving injectables has commenced operation today with products ranging from anti-infectives to stroke and trauma management, the company said in a statement.
Source: The Economic Times Healthcare and Biotech News - January 20, 2022 Category: Pharmaceuticals Source Type: news
AAN Position Statement Addresses Consent Issues in Acute Stroke
WEDNESDAY, Jan. 19, 2022 -- Issues relating to consent for people who have experienced acute ischemic stroke are addressed in an American Academy of Neurology position statement published online Jan. 10 in Neurology.
Justin A. Sattin, M.D., from...
Source: Drugs.com - Pharma News - January 19, 2022 Category: Pharmaceuticals Source Type: news
New Device Safe, Effective for Treating Brain Aneurysms
THURSDAY, Jan. 13, 2022 -- Real-world use shows the Woven EndoBridge (WEB) device is safe and effective for treating brain aneurysms, according to a research letter published online Dec. 17 in Stroke.
Adam A. Dmytriw, M.D., from Massachusetts...
Source: Drugs.com - Pharma News - January 13, 2022 Category: Pharmaceuticals Source Type: news
Next Billion-Dollar Startups: How Viz.ai Helps Hospitals Treat Stroke Patients Earlier (Video)
When a stroke patient arrives at the ER, every minute counts. Viz.ai uses artificial intelligence to treat patients earlier.
Source: Forbes.com Healthcare News - January 3, 2022 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Source Type: news
FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease who have...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Global, Regional, National Burden of Ischemic Stroke Estimated
THURSDAY, Dec. 16, 2021 -- Although there was a slight decrease in the worldwide incidence and mortality rates from 1990 to 2019, the burden of ischemic stroke remains high, according to a study published online Dec. 15 in Neurology.
Quanquan Ding,...
Source: Drugs.com - Pharma News - December 16, 2021 Category: Pharmaceuticals Source Type: news
Nuance — Not Doctrinaire Mandates — Is The Winning Formula For Healthcare
By using a broad brush to make healthcare decisions for tens of millions of Americans in one stroke, vaccine mandates cause many people to feel that their basic freedom of choice is being unjustly taken from them, and they resist predictably.
Source: Forbes.com Healthcare News - November 19, 2021 Category: Pharmaceuticals Authors: Rita Numerof, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Coffee and tea drinking may be associated with reduced rates of stroke and dementia
Drinking coffee or tea may be associated with a lower risk of stroke and dementia, according to a study of healthy individuals aged 50-74 publishing November 16th in the open-access journal PLOS Medicine. Drinking coffee was also associated with a lower risk of post-stroke dementia.
Source: World Pharma News - November 16, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across a Wide Range of Doses
This study establishes proof-of-principle for milvexian as a differentiated antithrombotic agent,” said Jeffrey Weitz, M.D., Professor of Medicine & Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis and Atherosclerosis Research Institute.[i] “Furthermore, the consistently low rates of bleeding across a 16-fold range of milvexian doses suggest that it has a wide therapeutic window, which opens the opportunity to explore milvexian across a broad range of patients including those for whom factor Xa inhibitors are underutilized or not indicated.” The trial met both o...
Source: Johnson and Johnson - November 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
NovaSignal ’s AI-Guided Robotic Platform Aims To Change The Diagnosis Of Stroke
Los Angeles based NovaSignal recently launched the second version of their artificial intelligence-guided robotic platform for assessing cerebral blood flow. Their goal is to guide real-time diagnosis.
Source: Forbes.com Healthcare News - October 29, 2021 Category: Pharmaceuticals Authors: Gabriel A. Silva, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Japan points the way in care for the elderly
A stroke prevention scheme in a small city shows the benefits of a joined-up approach to healthcare
Source: FT.com - Drugs and Healthcare - October 25, 2021 Category: Pharmaceuticals Source Type: news
Aspirin use to prevent 1st heart attack or stroke should be curtailed, US panel says
The U.S. panel also plans to retreat from its 2016 recommendation to take baby aspirin for the prevention of colorectal cancer, guidance that was groundbreaking at the time. The panel said that more recent data had raised questions about the putative benefits for cancer, and that more research was needed.
Source: The Economic Times Healthcare and Biotech News - October 12, 2021 Category: Pharmaceuticals Source Type: news
